Browsing Tag
radiopharmaceutical trials
1 post
Archeus Technologies receives FDA clearance for ART-101 to begin prostate cancer therapy trials in 2025
Archeus Technologies wins FDA IND clearance for ART-101, an alpha-emitting radiopharmaceutical therapy targeting PSMA in advanced prostate cancer.